Quantifiable analysis of cellular pathway inhibition of a Nedd8-activating enzyme inhibitor, MLN4924, using AlphaScreen

被引:7
作者
Yan, Zhong-Hua [1 ]
Burkhardt, Anne [1 ]
Loke, Huay-Keng [1 ]
Chen, Jesse [1 ]
Xu, Qing [1 ]
Brauer, Pam [1 ]
Ma, Jingya [1 ]
Lin, Yafang [1 ]
Garcia, Khris [1 ]
Dick, Lawrence R. [1 ]
Bembenek, Michael E. [1 ]
机构
[1] Millennium Pharmaceut Inc, Cambridge, MA 02139 USA
关键词
MLN4924; AlphaScreen; Cell-based assay; Pathway inhibition; CANCER; ACTIVATION;
D O I
10.1016/j.ab.2013.04.016
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Cellular effects of a Nedd8-activating enzyme (NAE) inhibitor, MLN4924, using the AlphaScreen format were explored. MLN4924 acts as a substrate-assisted inhibitor of NAE by forming a tight binding Nedd8-MLN4924 adduct. The inhibited enzyme can no longer transfer Nedd8 downstream to modify and activate the E3 cullin-RING ligases. This results in the stabilization of proteins regulated by the proteasome, leading to cell death. These studies monitored the endogenous cellular changes to NAE similar to Nedd8 thioester, the formation of the Nedd8-MLN4924 adduct, and the reduction in the Cul1-Nedd8. Lysates derived from MLN4924-treated HCT116 cells showed that whereas the beta-subunit of NAE remained constant, reductions of both NAE similar to Nedd8 thioester and Cul1-Nedd8 levels occurred with a concomitant rise of the adduct. Moreover, the formation of the Nedd8-MLN4924 adduct was approximately stoichiometric with the concentration of NAE beta. Higher density 384-well cell-based assays illustrated the kinetics of enzyme inactivation across a wider range of MLN4924 concentrations, showing a rapid loss of NAE similar to Nedd8 thioester and Cul1-Nedd8. The reduction of NAE similar to Nedd8 thioester precedes the loss of Cul1-Nedd8 at twice the rate. Finally, these results clearly demonstrate the utility of the homogeneous assay for quantitative assessment of these endogenous cellular components in a 384-well plate in response to inhibition of NAE by MLN4924. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:109 / 115
页数:7
相关论文
共 36 条
[31]   Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes [J].
Swords, R. T. ;
Watts, J. ;
Erba, H. P. ;
Altman, J. K. ;
Maris, M. ;
Anwer, F. ;
Hua, Z. ;
Stein, H. ;
Faessel, H. ;
Sedarati, F. ;
Dezube, B. J. ;
Giles, F. J. ;
Medeiros, B. C. ;
DeAngelo, D. J. .
BLOOD CANCER JOURNAL, 2017, 7 :e520-e520
[32]   Pevonedistat, a Nedd8-activating enzyme inhibitor, sensitizes neoplastic B-cells to death receptor-mediated apoptosis [J].
Paiva, Cody ;
Godbersen, J. Claire ;
Rowland, Taylor ;
Danilova, Olga V. ;
Danes, Christopher ;
Berger, Allison ;
Danilov, Alexey V. .
ONCOTARGET, 2017, 8 (13) :21128-21139
[33]   Neural precursor cell expressed, developmentally downregulated 8-activating enzyme inhibitor MLN4924 sensitizes colorectal cancer cells to oxaliplatin by inducing DNA damage, G2 cell cycle arrest and apoptosis [J].
Zheng, Wanwei ;
Luo, Zhongguang ;
Zhang, Jun ;
Min, Pei ;
Li, Wenshuai ;
Xu, Diannan ;
Zhang, Ziqiang ;
Xiong, Panpan ;
Liang, Hong ;
Liu, Jie .
MOLECULAR MEDICINE REPORTS, 2017, 15 (05) :2795-2801
[34]   Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication [J].
Ishikawa, Y. ;
Nakayama, K. ;
Morimoto, M. ;
Mizutani, A. ;
Nakayama, A. ;
Toyoshima, K. ;
Hayashi, A. ;
Takagi, S. ;
Dairiki, R. ;
Miyashita, H. ;
Matsumoto, S. ;
Gamo, K. ;
Nomura, T. ;
Nakamura, K. .
ONCOGENESIS, 2017, 6 :e377-e377
[35]   Immunomodulatory effect of NEDD8-activating enzyme inhibition in Multiple Myeloma: upregulation of NKG2D ligands and sensitization to Natural Killer cell recognition [J].
Petillo, Sara ;
Capuano, Cristina ;
Molfetta, Rosa ;
Fionda, Cinzia ;
Mekhloufi, Abdelilah ;
Pighi, Chiara ;
Antonangeli, Fabrizio ;
Zingoni, Alessandra ;
Soriani, Alessandra ;
Petrucci, Maria Teresa ;
Galandrini, Ricciarda ;
Paolini, Rossella ;
Santoni, Angela ;
Cippitelli, Marco .
CELL DEATH & DISEASE, 2021, 12 (09)
[36]   Pevonedistat, a NEDD8-activating enzyme inhibitor, induces apoptosis and augments efficacy of chemotherapy and small molecule inhibitors in pre-clinical models of diffuse large B-cell lymphoma [J].
Torka, Pallawi ;
Mavis, Cory ;
Kothari, Shalin ;
Belliotti, Sarah ;
Gu, Juan ;
Sundaram, Suchitra ;
Barth, Matthew ;
Hernandez-Ilizaliturri, Francisco J. .
EJHAEM, 2020, 1 (01) :122-132